L. Estebaranz
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune and Inflammatory Disorders Research, Autoimmune Bullous Skin Diseases, Pregnancy and Medication Impact
Most-Cited Works
- → One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis(2013)37 cited
- → Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)(2013)27 cited